Safety of and Immune Response to an HIV-1 Vaccine (VRC-HIVDNA016-00-VP) and a Vaccine Booster (VRC-HIVADV014-00-VP) in HIV Uninfected East African Adults

NCT00123968 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

326

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: VRC-HIVDNA016-00-VP
BIOLOGICAL: VRC-HIVADV014-00-VP
BIOLOGICAL: VRC-DILUENT013-DIL-VP
BIOLOGICAL: VRC-HIVADV014-00-VP placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]